Novel PET Tracer Detects Brain Astrocyte Reactivity
|
By MedImaging International staff writers Posted on 11 Aug 2021 |
|
Mapping analysis of significantly increased 11C-BU99008 uptake (Image courtesy of Molecular Psychiatry)
A choline-based positron emission tomography (PET) tracer can be used to identify brain activity involved in the formation of amyloid plaque in people with cognitive impairment and Alzheimer's disease (AD), according to a new study.
Researchers at Imperial College London (Imperial; United Kingdom), Cardiff University (United Kingdom), and other institutions enrolled 11 older, cognitively impaired subjects and nine age-matched healthy controls in a study of the viability of 11C-BU99008, a new PET tracer, to selectively image astrocyte reactivity, which may precede early pathological signs of AD, such as the formation of β-amyloid plaque and tau tangles. The patients also underwent 3T magnetic resonance imaging (MRI) and 18F-florbetaben PET imaging to identify β-amyloid plaque.
The results showed that 11C-BU99008 uptake was higher in eight β-amyloid-positive patients with cognitive impairment across the whole brain, but particularly in frontal, temporal, medial temporal, and occipital lobes, compared with the control group. Biological parametric mapping demonstrated a positive voxel-wise neuroanatomical correlation between 11C-BU99008 and 18F-florbetaben uptake, confirming that 11C-BU99008 could measure astrocyte reactivity. The study was published on July 15, 2021, in Molecular Psychiatry.
“This proof-of-concept study provides direct evidence that 11C-BU99008 can measure in vivo astrocyte reactivity in people with late-life cognitive impairment and Alzheimer's disease,” concluded senior author Paul Edison, PhD, of the Imperial department of brain sciences, and colleagues. “Our results confirm that increased astrocyte reactivity is found particularly in cortical regions with high β-amyloid load.”
Astrocytes have a wide range of roles in the central nervous system, and astrocyte reactivity can increase the expression of inflammatory mediators, reactive oxygen species (ROS), and β-amyloid deposition. In fact, it has been suggested that astrocyte reactivity may be a tissue response to β-amyloid and may have a protective role by phagocytosing and degrading it. Minimally invasive methods for monitoring astrocyte reactivity in patients with late-life cognitive impairment can provide a tool for testing their contributions to disease progression.
Related Links:
Imperial College London
Cardiff University
Researchers at Imperial College London (Imperial; United Kingdom), Cardiff University (United Kingdom), and other institutions enrolled 11 older, cognitively impaired subjects and nine age-matched healthy controls in a study of the viability of 11C-BU99008, a new PET tracer, to selectively image astrocyte reactivity, which may precede early pathological signs of AD, such as the formation of β-amyloid plaque and tau tangles. The patients also underwent 3T magnetic resonance imaging (MRI) and 18F-florbetaben PET imaging to identify β-amyloid plaque.
The results showed that 11C-BU99008 uptake was higher in eight β-amyloid-positive patients with cognitive impairment across the whole brain, but particularly in frontal, temporal, medial temporal, and occipital lobes, compared with the control group. Biological parametric mapping demonstrated a positive voxel-wise neuroanatomical correlation between 11C-BU99008 and 18F-florbetaben uptake, confirming that 11C-BU99008 could measure astrocyte reactivity. The study was published on July 15, 2021, in Molecular Psychiatry.
“This proof-of-concept study provides direct evidence that 11C-BU99008 can measure in vivo astrocyte reactivity in people with late-life cognitive impairment and Alzheimer's disease,” concluded senior author Paul Edison, PhD, of the Imperial department of brain sciences, and colleagues. “Our results confirm that increased astrocyte reactivity is found particularly in cortical regions with high β-amyloid load.”
Astrocytes have a wide range of roles in the central nervous system, and astrocyte reactivity can increase the expression of inflammatory mediators, reactive oxygen species (ROS), and β-amyloid deposition. In fact, it has been suggested that astrocyte reactivity may be a tissue response to β-amyloid and may have a protective role by phagocytosing and degrading it. Minimally invasive methods for monitoring astrocyte reactivity in patients with late-life cognitive impairment can provide a tool for testing their contributions to disease progression.
Related Links:
Imperial College London
Cardiff University
Radiation Therapy Treatment Software Application
Elekta ONE
Portable Color Doppler Ultrasound System
S5000
New
Radiation Shielding
Oversize Thyroid Shield
Silver Member
X-Ray QA Meter
T3 AD Pro
Latest General/Advanced Imaging News
- AI-Powered Imaging System Improves Lung Cancer Diagnosis
- AI Model Significantly Enhances Low-Dose CT Capabilities
- Ultra-Low Dose CT Aids Pneumonia Diagnosis in Immunocompromised Patients
- AI Reduces CT Lung Cancer Screening Workload by Almost 80%
- Cutting-Edge Technology Combines Light and Sound for Real-Time Stroke Monitoring
- AI System Detects Subtle Changes in Series of Medical Images Over Time
- New CT Scan Technique to Improve Prognosis and Treatments for Head and Neck Cancers
- World’s First Mobile Whole-Body CT Scanner to Provide Diagnostics at POC
- Comprehensive CT Scans Could Identify Atherosclerosis Among Lung Cancer Patients
- AI Improves Detection of Colorectal Cancer on Routine Abdominopelvic CT Scans
- Super-Resolution Technology Enhances Clinical Bone Imaging to Predict Osteoporotic Fracture Risk
- AI-Powered Abdomen Map Enables Early Cancer Detection
- Deep Learning Model Detects Lung Tumors on CT
- AI Predicts Cardiovascular Risk from CT Scans
- Deep Learning Based Algorithms Improve Tumor Detection in PET/CT Scans
- New Technology Provides Coronary Artery Calcification Scoring on Ungated Chest CT Scans
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read more
MRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel
Ultrasound-Based Microscopy Technique to Help Diagnose Small Vessel Diseases
Clinical ultrasound, commonly used in pregnancy scans, provides real-time images of body structures. It is one of the most widely used imaging techniques in medicine, but until recently, it had little... Read more
Smart Ultrasound-Activated Immune Cells Destroy Cancer Cells for Extended Periods
Chimeric antigen receptor (CAR) T-cell therapy has emerged as a highly promising cancer treatment, especially for bloodborne cancers like leukemia. This highly personalized therapy involves extracting... Read more
Nuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read more
Imaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more